Speakers

Aparna Dagar PhD, RAC is Vice President, Regulatory Affairs at Fresenius Kabi USA, LLC., where she leads the regulatory function and provides strategic regulatory leadership across the company’s Generics, 505(b)(1) and 505(b)(2) portfolio. With over 21 years in the pharmaceutical industry, she has held positions in R&D and Regulatory Affairs with experience spanning oral, parenteral and combination drug development. At Fresenius Kabi, Aparna plays a key role in developing and implementing regulatory, clinical and CMC strategies to facilitate product development and approval in the US. Aparna Dagar graduated from the University of Illinois at Chicago where she received her PhD in Biopharmaceutical Sciences.